E Fund Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.2K	Buy	+14,709	New	+$76.6K	﹤0.01%	482
2025 Q2	$66.8K	Sell	12,575 -1,145	-8%	-$6.76K	﹤0.01%	386
2025 Q1	$122K	Buy	13,720 +1,968	+17%	+$23.6K	0.01%	378
2024 Q4	$161K	Buy	+11,752	New	+$217K	0.01%	372
2024 Q2	–	Sell	-11,776	Closed	-$251K	–	355
2024 Q1	$251K	Buy	+11,776	New	+$253K	0.02%	299
2023 Q4	–	Sell	-10,709	Closed	-$172K	–	322
2023 Q3	$172K	Buy	10,709 +159	+2%	+$3.03K	0.01%	265
2023 Q2	$245K	Buy	10,550 +911	+9%	+$19.9K	0.02%	248
2023 Q1	$224K	Sell	9,639 -1,183	-11%	-$24K	0.02%	279
2022 Q4	$157K	Sell	10,822 -961	-8%	-$17.9K	0.01%	314
2022 Q3	$225K	Sell	11,783 -698	-6%	-$16K	0.02%	283
2022 Q2	$227K	Buy	+12,481	New	+$259K	0.02%	278